In two clinical trials, the following adverse events occurred at least 5% more frequently in patients treated with<unk>  than in the placebo group: fever, diarrhoea, rash, ulcers of the mouth area, joint pain (arthralgia) and urinary tract infections. Additional adverse events for the infantile-onset population included upper respiratory tract infection, pneumonia, constipation and vomiting.<unk>  should not be taken together with medications that are multidrug and toxin extrusion (MATE) substrates because<unk>  may increase plasma concentrations of these drugs.
Risdiplam
Lemborexant
Fenproporex
Tasimelteon
Fosaprepitant
Bocasan
Mitapivat
Pleconaril